Crossmark

Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study

Crossref DOI link: https://doi.org/10.1007/s00296-020-04746-7

Published Online: 2020-11-30

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pappas, Dimitrios A. https://orcid.org/0000-0001-8338-027X
Brittle, Christine https://orcid.org/0000-0001-6792-5970
Mossell, James E. III

Withers, Johanna B. https://orcid.org/0000-0003-1289-4454
Lim-Harashima, Jeraldine https://orcid.org/0000-0002-8201-7601
Kremer, Joel M. https://orcid.org/0000-0001-6674-9901
Funding

Funding for this research was provided by:

Scipher Medicine Corporation
License Information

Text and Data Mining valid from 2020-11-30

Version of Record valid from 2020-11-30
More Information

Article History

Received: 17 August 2020

Accepted: 29 October 2020

First Online: 30 November 2020

Document is current

Any future updates will be listed below